Cargando…
Regulation of Intrinsic Functions of PD-L1 by Post-Translational Modification in Tumors
Tumor cells are eliminated by the immune system, including T lymphocytes and natural killer cells; however, many types of tumor cells acquire the immune tolerance by inhibiting T-cell activation and functions via immune checkpoint molecules. Immunotherapy targeting immune checkpoint molecules such a...
Autores principales: | Nihira, Naoe Taira, Miki, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984111/ https://www.ncbi.nlm.nih.gov/pubmed/35402280 http://dx.doi.org/10.3389/fonc.2022.825284 |
Ejemplares similares
-
Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume II
por: Nihira, Naoe Taira, et al.
Publicado: (2023) -
Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy
por: Feng, Chong, et al.
Publicado: (2023) -
Regulation of the tumor suppressor PML by sequential post-translational modifications
por: Schmitz, M. Lienhard, et al.
Publicado: (2012) -
Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor
por: Liu, Na, et al.
Publicado: (2022) -
Post-translational modifications and their implications in cancer
por: Dutta, Hashnu, et al.
Publicado: (2023)